203 related articles for article (PubMed ID: 37468671)
41. Changes in the disease burden of breast cancer along with attributable risk factors in China from 1990 to 2019 and its projections: An analysis of the global burden of disease study 2019.
Li J; Chen C; Nie J; Wang L; Zhang Z; Li Y
Cancer Med; 2023 Jan; 12(2):1888-1902. PubMed ID: 35785526
[TBL] [Abstract][Full Text] [Related]
42. Increased expression of protease-activated receptor 1 (PAR-1) in human leukemias.
Veiga Cde S; Carneiro-Lobo TC; Coelho CJ; Carvalho SM; Maia RC; Vasconcelos FC; Abdelhay E; Mencalha AL; Ferreira AF; Castro FA; Monteiro RQ
Blood Cells Mol Dis; 2011 Mar; 46(3):230-4. PubMed ID: 21216163
[TBL] [Abstract][Full Text] [Related]
43. The long-term trend of Parkinson's disease incidence and mortality in China and a Bayesian projection from 2020 to 2030.
Chen F; Chen S; Si A; Luo Y; Hu W; Zhang Y; Ma J
Front Aging Neurosci; 2022; 14():973310. PubMed ID: 36185486
[No Abstract] [Full Text] [Related]
44. Time Trends in the Incidence of Spinal Pain in China, 1990 to 2019 and Its Prediction to 2030: The Global Burden of Disease Study 2019.
Wei J; Chen L; Huang S; Li Y; Zheng J; Cheng Z; Xie Z
Pain Ther; 2022 Dec; 11(4):1245-1266. PubMed ID: 35969366
[TBL] [Abstract][Full Text] [Related]
45. Incidence of leukemia in Olmsted County, Minnesota, 1975 through 1989.
Call TG; Noël P; Habermann TM; Beard CM; O'Fallon WM; Kurland LT
Mayo Clin Proc; 1994 Apr; 69(4):315-22. PubMed ID: 8170174
[TBL] [Abstract][Full Text] [Related]
46. Childbearing and the risk of leukemia in Sweden.
Ekström K; Wuu J; Hsieh CC; Glimelius B; Lambe M
Cancer Causes Control; 2002 Feb; 13(1):47-53. PubMed ID: 11899117
[TBL] [Abstract][Full Text] [Related]
47. Long-term trends in the burden of edentulism in China over three decades: A Joinpoint regression and age-period-cohort analysis based on the global burden of disease study 2019.
Qin X; He J; He H; Yuan X; Su X; Zeng X
Front Public Health; 2023; 11():1099194. PubMed ID: 37181712
[TBL] [Abstract][Full Text] [Related]
48. Trends in the incidence of leukaemia in Poland, 1963-90: an epidemiologic study.
Kwiatkowski A
Eur J Cancer Prev; 1994 May; 3(3):277-83. PubMed ID: 8061593
[TBL] [Abstract][Full Text] [Related]
49. An emerging trend of rapid increase of leukemia but not all cancers in the aging population in the United States.
Hao T; Li-Talley M; Buck A; Chen W
Sci Rep; 2019 Aug; 9(1):12070. PubMed ID: 31427635
[TBL] [Abstract][Full Text] [Related]
50. [Trend analysis and prediction of cancer incidence in China].
Chen WQ; Zheng RS; Zeng HM; Zhang SW; Li N; Zou XN; He J
Zhonghua Yu Fang Yi Xue Za Zhi; 2012 Jul; 46(7):581-6. PubMed ID: 22943910
[TBL] [Abstract][Full Text] [Related]
51. Secular Trends in the Incidence of and Mortality Due to Alzheimer's Disease and Other Forms of Dementia in China From 1990 to 2019: An Age-Period-Cohort Study and Joinpoint Analysis.
Gao Y; Liu X
Front Aging Neurosci; 2021; 13():709156. PubMed ID: 34539380
[TBL] [Abstract][Full Text] [Related]
52. Specific cutaneous infiltrates in patients with myelogenous leukemia: a clinicopathologic study of 26 patients with assessment of diagnostic criteria.
Kaddu S; Zenahlik P; Beham-Schmid C; Kerl H; Cerroni L
J Am Acad Dermatol; 1999 Jun; 40(6 Pt 1):966-78. PubMed ID: 10365929
[TBL] [Abstract][Full Text] [Related]
53. Burden of pancreatic cancer along with attributable risk factors in China from 1990 to 2019, and projections until 2030.
Chen J; Chen H; Zhang T; Yin X; Man J; Yang X; Lu M
Pancreatology; 2022 Jun; 22(5):608-618. PubMed ID: 35513974
[TBL] [Abstract][Full Text] [Related]
54. Trends and age-period-cohort effect on incidence and mortality of prostate cancer from 1990 to 2017 in China.
Liu X; Yu C; Bi Y; Zhang ZJ
Public Health; 2019 Jul; 172():70-80. PubMed ID: 31220754
[TBL] [Abstract][Full Text] [Related]
55. Trends in the Incidence and Mortality of Diabetes in China from 1990 to 2017: A Joinpoint and Age-Period-Cohort Analysis.
Liu X; Yu C; Wang Y; Bi Y; Liu Y; Zhang ZJ
Int J Environ Res Public Health; 2019 Jan; 16(1):. PubMed ID: 30626127
[No Abstract] [Full Text] [Related]
56. Myelodysplastic syndrome and benzene exposure among petroleum workers: an international pooled analysis.
Schnatter AR; Glass DC; Tang G; Irons RD; Rushton L
J Natl Cancer Inst; 2012 Nov; 104(22):1724-37. PubMed ID: 23111193
[TBL] [Abstract][Full Text] [Related]
57. Burden of carbon monoxide poisoning in China, 1990-2019: A systematic analysis of data from the global burden of disease study 2019.
Cui P; Jin Y; Feng H; Li Z; Ding S; Li Y
Front Public Health; 2022; 10():930784. PubMed ID: 35968482
[TBL] [Abstract][Full Text] [Related]
58. Telomerase activity and telomere length in acute and chronic leukemia, pre- and post-ex vivo culture.
Engelhardt M; Mackenzie K; Drullinsky P; Silver RT; Moore MA
Cancer Res; 2000 Feb; 60(3):610-7. PubMed ID: 10676644
[TBL] [Abstract][Full Text] [Related]
59. Biologically-based risk estimation for radiation-induced chronic myeloid leukemia.
Radivoyevitch T; Hoel DG
Radiat Environ Biophys; 2000 Sep; 39(3):153-9. PubMed ID: 11095145
[TBL] [Abstract][Full Text] [Related]
60. The global burden and attributable risk factor analysis of acute myeloid leukemia in 195 countries and territories from 1990 to 2017: estimates based on the global burden of disease study 2017.
Yi M; Li A; Zhou L; Chu Q; Song Y; Wu K
J Hematol Oncol; 2020 Jun; 13(1):72. PubMed ID: 32513227
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
